nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—liver cancer	0.339	1	CbGaD
Enzalutamide—CYP2B6—Sorafenib—liver cancer	0.0756	0.156	CbGbCtD
Enzalutamide—CYP3A5—Sorafenib—liver cancer	0.0595	0.123	CbGbCtD
Enzalutamide—CYP2C8—Sorafenib—liver cancer	0.0572	0.118	CbGbCtD
Enzalutamide—CYP2C19—Sorafenib—liver cancer	0.048	0.0992	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—liver cancer	0.0459	0.0947	CbGbCtD
Enzalutamide—CYP2C9—Sorafenib—liver cancer	0.0399	0.0824	CbGbCtD
Enzalutamide—ABCB1—Sorafenib—liver cancer	0.0387	0.08	CbGbCtD
Enzalutamide—CYP2D6—Sorafenib—liver cancer	0.0365	0.0754	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—liver cancer	0.0235	0.0485	CbGbCtD
Enzalutamide—CYP3A4—Sorafenib—liver cancer	0.0232	0.0479	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—liver cancer	0.0222	0.0457	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—liver cancer	0.0141	0.0291	CbGbCtD
Enzalutamide—Haematoma—Sorafenib—liver cancer	0.00281	0.0526	CcSEcCtD
Enzalutamide—Dry skin—Sorafenib—liver cancer	0.00118	0.022	CcSEcCtD
Enzalutamide—Nasopharyngitis—Sorafenib—liver cancer	0.00115	0.0215	CcSEcCtD
Enzalutamide—Neutropenia—Sorafenib—liver cancer	0.00104	0.0194	CcSEcCtD
Enzalutamide—Pneumonia—Sorafenib—liver cancer	0.000994	0.0186	CcSEcCtD
Enzalutamide—Infestation NOS—Sorafenib—liver cancer	0.000988	0.0185	CcSEcCtD
Enzalutamide—Infestation—Sorafenib—liver cancer	0.000988	0.0185	CcSEcCtD
Enzalutamide—Epistaxis—Sorafenib—liver cancer	0.000932	0.0174	CcSEcCtD
Enzalutamide—Laryngitis—Epirubicin—liver cancer	0.000906	0.017	CcSEcCtD
Enzalutamide—Urinary tract disorder—Sorafenib—liver cancer	0.000876	0.0164	CcSEcCtD
Enzalutamide—Connective tissue disorder—Sorafenib—liver cancer	0.000872	0.0163	CcSEcCtD
Enzalutamide—Urethral disorder—Sorafenib—liver cancer	0.00087	0.0163	CcSEcCtD
Enzalutamide—Laryngitis—Doxorubicin—liver cancer	0.000838	0.0157	CcSEcCtD
Enzalutamide—Angiopathy—Sorafenib—liver cancer	0.000805	0.0151	CcSEcCtD
Enzalutamide—Mental disorder—Sorafenib—liver cancer	0.000777	0.0145	CcSEcCtD
Enzalutamide—Leukopenia—Sorafenib—liver cancer	0.000691	0.0129	CcSEcCtD
Enzalutamide—Hypertension—Sorafenib—liver cancer	0.000667	0.0125	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Epirubicin—liver cancer	0.000661	0.0124	CcSEcCtD
Enzalutamide—Arthralgia—Sorafenib—liver cancer	0.000658	0.0123	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000653	0.0122	CcSEcCtD
Enzalutamide—Infection—Sorafenib—liver cancer	0.000626	0.0117	CcSEcCtD
Enzalutamide—Nervous system disorder—Sorafenib—liver cancer	0.000618	0.0116	CcSEcCtD
Enzalutamide—Thrombocytopenia—Sorafenib—liver cancer	0.000617	0.0116	CcSEcCtD
Enzalutamide—Skin disorder—Sorafenib—liver cancer	0.000612	0.0115	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—liver cancer	0.000612	0.0114	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000574	0.0107	CcSEcCtD
Enzalutamide—Sepsis—Epirubicin—liver cancer	0.000567	0.0106	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Sorafenib—liver cancer	0.000544	0.0102	CcSEcCtD
Enzalutamide—Fatigue—Sorafenib—liver cancer	0.000543	0.0102	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—liver cancer	0.000524	0.00981	CcSEcCtD
Enzalutamide—Hot flush—Epirubicin—liver cancer	0.000507	0.00948	CcSEcCtD
Enzalutamide—Menopausal symptoms—Epirubicin—liver cancer	0.000502	0.0094	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—liver cancer	0.000469	0.00878	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—liver cancer	0.000465	0.0087	CcSEcCtD
Enzalutamide—Asthenia—Sorafenib—liver cancer	0.000452	0.00847	CcSEcCtD
Enzalutamide—Pruritus—Sorafenib—liver cancer	0.000446	0.00835	CcSEcCtD
Enzalutamide—Dry skin—Epirubicin—liver cancer	0.000434	0.00813	CcSEcCtD
Enzalutamide—Diarrhoea—Sorafenib—liver cancer	0.000431	0.00807	CcSEcCtD
Enzalutamide—Nasopharyngitis—Epirubicin—liver cancer	0.000424	0.00793	CcSEcCtD
Enzalutamide—Muscular weakness—Epirubicin—liver cancer	0.000418	0.00782	CcSEcCtD
Enzalutamide—Dizziness—Sorafenib—liver cancer	0.000417	0.0078	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—liver cancer	0.000402	0.00752	CcSEcCtD
Enzalutamide—Headache—Sorafenib—liver cancer	0.000395	0.00739	CcSEcCtD
Enzalutamide—Bronchitis—Epirubicin—liver cancer	0.000394	0.00737	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—liver cancer	0.000392	0.00734	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—liver cancer	0.000387	0.00724	CcSEcCtD
Enzalutamide—Neutropenia—Epirubicin—liver cancer	0.000383	0.00717	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Epirubicin—liver cancer	0.000381	0.00713	CcSEcCtD
Enzalutamide—Pollakiuria—Epirubicin—liver cancer	0.000378	0.00708	CcSEcCtD
Enzalutamide—Pneumonia—Epirubicin—liver cancer	0.000367	0.00688	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—liver cancer	0.000365	0.00684	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—liver cancer	0.000365	0.00684	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—liver cancer	0.000365	0.00682	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—liver cancer	0.000354	0.00663	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000352	0.00659	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—liver cancer	0.00035	0.00655	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—liver cancer	0.000348	0.00652	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—liver cancer	0.000345	0.00645	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—liver cancer	0.000343	0.00641	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—liver cancer	0.00034	0.00636	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—liver cancer	0.000338	0.00633	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—liver cancer	0.000338	0.00633	CcSEcCtD
Enzalutamide—Rhinitis—Epirubicin—liver cancer	0.000329	0.00615	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—liver cancer	0.000326	0.00611	CcSEcCtD
Enzalutamide—Pharyngitis—Epirubicin—liver cancer	0.000325	0.00609	CcSEcCtD
Enzalutamide—Urinary tract disorder—Epirubicin—liver cancer	0.000324	0.00606	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—liver cancer	0.000323	0.00605	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—liver cancer	0.000322	0.00603	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—liver cancer	0.000322	0.00603	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—liver cancer	0.000321	0.00602	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—liver cancer	0.000319	0.00597	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—liver cancer	0.000317	0.00593	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—liver cancer	0.000304	0.00569	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—liver cancer	0.000302	0.00565	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—liver cancer	0.000301	0.00564	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—liver cancer	0.0003	0.00561	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—liver cancer	0.000299	0.00559	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—liver cancer	0.000298	0.00558	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—liver cancer	0.000297	0.00557	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—liver cancer	0.000297	0.00557	CcSEcCtD
Enzalutamide—Mental disorder—Epirubicin—liver cancer	0.000287	0.00538	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—liver cancer	0.000276	0.00517	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—liver cancer	0.000275	0.00515	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—liver cancer	0.000266	0.00498	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—liver cancer	0.000256	0.0048	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—liver cancer	0.000256	0.00478	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—liver cancer	0.000255	0.00478	CcSEcCtD
Enzalutamide—Convulsion—Epirubicin—liver cancer	0.000247	0.00463	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—liver cancer	0.000246	0.00461	CcSEcCtD
Enzalutamide—Arthralgia—Epirubicin—liver cancer	0.000243	0.00455	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—liver cancer	0.000242	0.00453	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000241	0.00452	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—liver cancer	0.000237	0.00444	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—liver cancer	0.000236	0.00443	CcSEcCtD
Enzalutamide—Infection—Epirubicin—liver cancer	0.000231	0.00433	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—liver cancer	0.000229	0.00428	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—liver cancer	0.000228	0.00428	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—liver cancer	0.000228	0.00427	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—liver cancer	0.000228	0.00427	CcSEcCtD
Enzalutamide—Skin disorder—Epirubicin—liver cancer	0.000226	0.00424	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—liver cancer	0.000225	0.00421	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—liver cancer	0.000224	0.00419	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000223	0.00418	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—liver cancer	0.000214	0.00401	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000212	0.00397	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—liver cancer	0.000211	0.00396	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—liver cancer	0.000211	0.00395	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—liver cancer	0.000211	0.00394	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—liver cancer	0.000209	0.00392	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—liver cancer	0.000209	0.00392	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000201	0.00376	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—liver cancer	0.000201	0.00376	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000196	0.00368	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—liver cancer	0.000195	0.00365	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—liver cancer	0.000194	0.00362	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000186	0.00348	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—liver cancer	0.000186	0.00348	CcSEcCtD
Enzalutamide—Asthenia—Epirubicin—liver cancer	0.000167	0.00313	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—liver cancer	0.000165	0.00308	CcSEcCtD
Enzalutamide—Diarrhoea—Epirubicin—liver cancer	0.000159	0.00298	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—liver cancer	0.000155	0.00289	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—liver cancer	0.000154	0.00288	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—liver cancer	0.000153	0.00285	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—liver cancer	0.000147	0.00276	CcSEcCtD
Enzalutamide—Headache—Epirubicin—liver cancer	0.000146	0.00273	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—liver cancer	0.000143	0.00267	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—liver cancer	0.000135	0.00253	CcSEcCtD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.05e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTA1—liver cancer	2.05e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PSMD10—liver cancer	2.05e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PSMA4—liver cancer	2.05e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NAT2—liver cancer	2.04e-05	0.000165	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.04e-05	0.000165	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GOT2—liver cancer	2.04e-05	0.000165	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CRABP1—liver cancer	2.03e-05	0.000164	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.03e-05	0.000164	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NAT2—liver cancer	2.03e-05	0.000164	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2e-05	0.000162	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GOT2—liver cancer	1.99e-05	0.000161	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HPGDS—liver cancer	1.99e-05	0.000161	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CRABP1—liver cancer	1.98e-05	0.00016	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.98e-05	0.00016	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HPGDS—liver cancer	1.98e-05	0.00016	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.98e-05	0.00016	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CD—liver cancer	1.97e-05	0.000159	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.97e-05	0.000159	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALDOB—liver cancer	1.96e-05	0.000158	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.95e-05	0.000158	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SERPINE1—liver cancer	1.95e-05	0.000157	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALDOB—liver cancer	1.94e-05	0.000157	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.93e-05	0.000156	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP2E1—liver cancer	1.92e-05	0.000155	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2E1—liver cancer	1.87e-05	0.000151	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CRABP1—liver cancer	1.87e-05	0.000151	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CRABP1—liver cancer	1.85e-05	0.00015	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.83e-05	0.000148	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.8e-05	0.000146	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYCS—liver cancer	1.79e-05	0.000145	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.79e-05	0.000145	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.78e-05	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HPGDS—liver cancer	1.78e-05	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PSMA4—liver cancer	1.77e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PSMD10—liver cancer	1.77e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.77e-05	0.000143	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PSMD10—liver cancer	1.76e-05	0.000143	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PSMA4—liver cancer	1.76e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GGT1—liver cancer	1.76e-05	0.000142	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GOT1—liver cancer	1.76e-05	0.000142	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—RAF1—liver cancer	1.76e-05	0.000142	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYCS—liver cancer	1.75e-05	0.000142	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HPGDS—liver cancer	1.73e-05	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GOT2—liver cancer	1.73e-05	0.00014	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GGT1—liver cancer	1.72e-05	0.000139	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GOT1—liver cancer	1.72e-05	0.000139	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GOT2—liver cancer	1.72e-05	0.000139	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CB—liver cancer	1.72e-05	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.67e-05	0.000135	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GLUL—liver cancer	1.66e-05	0.000134	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CPT1B—liver cancer	1.66e-05	0.000134	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.66e-05	0.000134	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HPGDS—liver cancer	1.63e-05	0.000132	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.63e-05	0.000132	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2E1—liver cancer	1.62e-05	0.000131	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HPGDS—liver cancer	1.62e-05	0.000131	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2E1—liver cancer	1.61e-05	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.61e-05	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.61e-05	0.00013	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NR1H4—liver cancer	1.6e-05	0.000129	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.59e-05	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PSMD10—liver cancer	1.58e-05	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PSMA4—liver cancer	1.58e-05	0.000128	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTP1—liver cancer	1.58e-05	0.000128	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—liver cancer	1.58e-05	0.000127	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA3—liver cancer	1.57e-05	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.57e-05	0.000127	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.56e-05	0.000126	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—HMOX1—liver cancer	1.56e-05	0.000126	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PSMA4—liver cancer	1.54e-05	0.000125	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PSMD10—liver cancer	1.54e-05	0.000125	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTP1—liver cancer	1.54e-05	0.000125	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GOT2—liver cancer	1.54e-05	0.000125	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HMOX1—liver cancer	1.52e-05	0.000123	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.52e-05	0.000123	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYCS—liver cancer	1.52e-05	0.000123	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYCS—liver cancer	1.51e-05	0.000122	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GOT2—liver cancer	1.5e-05	0.000122	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GGT1—liver cancer	1.49e-05	0.00012	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GOT1—liver cancer	1.49e-05	0.00012	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GGT1—liver cancer	1.48e-05	0.00012	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GOT1—liver cancer	1.48e-05	0.00012	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.47e-05	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.47e-05	0.000119	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PSMA4—liver cancer	1.46e-05	0.000118	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PSMD10—liver cancer	1.46e-05	0.000118	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—liver cancer	1.45e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2E1—liver cancer	1.45e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.45e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PSMA4—liver cancer	1.44e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PSMD10—liver cancer	1.44e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA4—liver cancer	1.44e-05	0.000116	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—liver cancer	1.42e-05	0.000115	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GOT2—liver cancer	1.42e-05	0.000115	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2E1—liver cancer	1.41e-05	0.000114	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GOT2—liver cancer	1.4e-05	0.000114	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.4e-05	0.000113	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA2—liver cancer	1.4e-05	0.000113	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—liver cancer	1.38e-05	0.000112	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1A1—liver cancer	1.38e-05	0.000111	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYCS—liver cancer	1.35e-05	0.00011	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA1—liver cancer	1.35e-05	0.000109	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1A1—liver cancer	1.35e-05	0.000109	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—liver cancer	1.34e-05	0.000108	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—liver cancer	1.34e-05	0.000108	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NAT2—liver cancer	1.34e-05	0.000108	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.33e-05	0.000108	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2E1—liver cancer	1.33e-05	0.000108	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—liver cancer	1.33e-05	0.000108	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GOT1—liver cancer	1.33e-05	0.000107	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GGT1—liver cancer	1.33e-05	0.000107	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYCS—liver cancer	1.32e-05	0.000107	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2E1—liver cancer	1.32e-05	0.000107	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—liver cancer	1.32e-05	0.000107	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—liver cancer	1.31e-05	0.000106	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GGT1—liver cancer	1.3e-05	0.000105	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GOT1—liver cancer	1.3e-05	0.000105	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—liver cancer	1.28e-05	0.000104	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDOB—liver cancer	1.28e-05	0.000104	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.28e-05	0.000103	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARA—liver cancer	1.26e-05	0.000102	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—liver cancer	1.25e-05	0.000101	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYCS—liver cancer	1.25e-05	0.000101	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYCS—liver cancer	1.24e-05	9.99e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARA—liver cancer	1.23e-05	9.95e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—liver cancer	1.23e-05	9.94e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—liver cancer	1.23e-05	9.94e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GOT1—liver cancer	1.22e-05	9.89e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GGT1—liver cancer	1.22e-05	9.89e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—liver cancer	1.22e-05	9.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CRABP1—liver cancer	1.22e-05	9.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GGT1—liver cancer	1.21e-05	9.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GOT1—liver cancer	1.21e-05	9.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—liver cancer	1.19e-05	9.66e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—liver cancer	1.18e-05	9.52e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—liver cancer	1.17e-05	9.42e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A1—liver cancer	1.17e-05	9.42e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A1—liver cancer	1.16e-05	9.37e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—liver cancer	1.15e-05	9.29e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—liver cancer	1.14e-05	9.2e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—liver cancer	1.1e-05	8.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—liver cancer	1.1e-05	8.87e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—liver cancer	1.09e-05	8.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—liver cancer	1.09e-05	8.79e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—liver cancer	1.08e-05	8.76e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—liver cancer	1.08e-05	8.74e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—liver cancer	1.08e-05	8.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—liver cancer	1.07e-05	8.68e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—liver cancer	1.07e-05	8.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HPGDS—liver cancer	1.07e-05	8.64e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARA—liver cancer	1.07e-05	8.62e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARA—liver cancer	1.06e-05	8.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—liver cancer	1.05e-05	8.52e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—liver cancer	1.05e-05	8.46e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—liver cancer	1.04e-05	8.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A1—liver cancer	1.04e-05	8.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—liver cancer	1.02e-05	8.23e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A1—liver cancer	1.02e-05	8.21e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—liver cancer	1.01e-05	8.18e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—liver cancer	1.01e-05	8.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—liver cancer	1e-05	8.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—liver cancer	9.7e-06	7.84e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—liver cancer	9.67e-06	7.82e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—liver cancer	9.57e-06	7.74e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.57e-06	7.74e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A1—liver cancer	9.57e-06	7.74e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.52e-06	7.7e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMA4—liver cancer	9.52e-06	7.7e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMD10—liver cancer	9.52e-06	7.7e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARA—liver cancer	9.51e-06	7.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A1—liver cancer	9.48e-06	7.67e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CD—liver cancer	9.48e-06	7.66e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—liver cancer	9.46e-06	7.65e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—liver cancer	9.36e-06	7.57e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARA—liver cancer	9.28e-06	7.51e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CD—liver cancer	9.26e-06	7.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GOT2—liver cancer	9.26e-06	7.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—liver cancer	9.14e-06	7.4e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—liver cancer	9.13e-06	7.38e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—liver cancer	9.08e-06	7.34e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—liver cancer	8.92e-06	7.21e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—liver cancer	8.84e-06	7.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—liver cancer	8.81e-06	7.12e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—liver cancer	8.76e-06	7.08e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARA—liver cancer	8.75e-06	7.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2E1—liver cancer	8.71e-06	7.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARA—liver cancer	8.67e-06	7.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.54e-06	6.91e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—liver cancer	8.54e-06	6.91e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CB—liver cancer	8.26e-06	6.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—liver cancer	8.15e-06	6.59e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYCS—liver cancer	8.15e-06	6.59e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CB—liver cancer	8.07e-06	6.53e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CD—liver cancer	8.02e-06	6.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GOT1—liver cancer	7.99e-06	6.46e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GGT1—liver cancer	7.99e-06	6.46e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CD—liver cancer	7.98e-06	6.45e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—liver cancer	7.95e-06	6.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—liver cancer	7.92e-06	6.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—liver cancer	7.86e-06	6.36e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.79e-06	6.3e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—liver cancer	7.67e-06	6.21e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—liver cancer	7.49e-06	6.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—liver cancer	7.43e-06	6.01e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—liver cancer	7.23e-06	5.85e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—liver cancer	7.18e-06	5.81e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—liver cancer	7.17e-06	5.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CD—liver cancer	7.16e-06	5.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—liver cancer	7.08e-06	5.73e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—liver cancer	7.07e-06	5.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CB—liver cancer	6.99e-06	5.66e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CD—liver cancer	6.99e-06	5.65e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CB—liver cancer	6.95e-06	5.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—liver cancer	6.9e-06	5.58e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—liver cancer	6.6e-06	5.34e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CD—liver cancer	6.59e-06	5.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CD—liver cancer	6.53e-06	5.28e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—liver cancer	6.5e-06	5.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—liver cancer	6.45e-06	5.21e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A1—liver cancer	6.25e-06	5.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CB—liver cancer	6.24e-06	5.05e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CB—liver cancer	6.09e-06	4.93e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—liver cancer	5.83e-06	4.72e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CB—liver cancer	5.74e-06	4.64e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARA—liver cancer	5.72e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CB—liver cancer	5.69e-06	4.6e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—liver cancer	5.04e-06	4.07e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—liver cancer	4.92e-06	3.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—liver cancer	4.9e-06	3.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—liver cancer	4.73e-06	3.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CD—liver cancer	4.31e-06	3.48e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—liver cancer	4.26e-06	3.45e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—liver cancer	4.25e-06	3.44e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—liver cancer	4.24e-06	3.43e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—liver cancer	4.11e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—liver cancer	4.02e-06	3.25e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—liver cancer	3.81e-06	3.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CB—liver cancer	3.75e-06	3.04e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—liver cancer	3.71e-06	3e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—liver cancer	3.5e-06	2.83e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—liver cancer	3.48e-06	2.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—liver cancer	3.47e-06	2.81e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—liver cancer	3.46e-06	2.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—liver cancer	3.11e-06	2.51e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—liver cancer	3.03e-06	2.45e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—liver cancer	2.86e-06	2.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—liver cancer	2.83e-06	2.29e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—liver cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—liver cancer	1.87e-06	1.51e-05	CbGpPWpGaD
